News

A multi-organoid system developed from human induced pluripotent stem cells can simulate human liver-islet axis in type 2 diabetes, providing a novel platform for type 2 diabetes research.

Many future gene and cell therapies to treat diseases like cancer, rare genetic and other conditions could be enhanced in their efficacy, persistence, and predictability by so-called “genomic safe harbors (GSHs).”

Research suggests that two proteins, apolipoprotein(a) and vascular cell adhesion molecule 1, influence how long and healthy a life we live.

An affinity peptide for the bone cancer niche has been attached to a breast cancer drug, and the combined therapy has shown promise for cancer treatment in rodent models.

An experimental drug called ION363 is being investigated in ALS patients in a global, Phase 3 clinical trial taking place in the United States, Europe and Asia.

A molecule found once broccoli is digested has been shown to trigger apoptosis in exponentially dividing cells, suggesting it could be used as a potential cancer treatment.

According to a new study, melanoma cells release small extracellular packages containing the protein nerve growth factor receptor, which primes nearby lymph nodes for tumor metastases.

Research has revealed the mechanism of action of the anticancer drug olaparib, used to treat triple-negative breast cancer.

A study has found that disease-modifying antirheumatic drugs were not associated with lower risk of Parkinson’s disease in individuals with rheumatoid arthritis.

Scientists have identified natural extracellular vesicles containing the ACE2 protein (evACE2) in the blood of COVID-19 patients that can block infection from broad strains of SARS-CoV-2 virus in preclinical studies.